![Quiver Logo](/static/img/logo-icon.png)
![NBTX logo](https://quiver-logos.s3.us-east-2.amazonaws.com/nbtx.png)
Nanobiotix S.A. American Depositary Shares
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NBTX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of NBTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NBTX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to NBTX
Recent picks made for NBTX stock on CNBC
ETFs with the largest estimated holdings in NBTX
Flights by private jets registered to NBTX
![Quiver Logo](/static/img/logo-icon.png)